BioWorld MedTech

Feb. 25, 2011

Deals roundup: Thermo Fisher in plan to sell diagnostic labs for $940M

Thermo Fisher Scientific (Waltham, Massachusetts) reported that it has signed definitive agreements to sell Athena Diagnostics (Worcester, Massachusetts) to Quest Diagnostics (Madison, New Jersey) for $740 million. (Medical Device Daily) Read More

Cook launches EchoTip ProCore, new histology needle for EUS

International report: Mazor's PIPE dreams up $6.3M in new capital funds for company

RFID Hospial Smart Room uses real-time patient data

Agreements/contracts: Masimo to license Pulse for Royal Fornia monitors

MDD's food for med-tech thought

New ventures: Biolase Technology forms new imaging business unit

Clarification

Product Briefs

HIT roundup: Lumedx launches Enabling EHR suite for meaningful use

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for March 25, 2026.

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 24, 2026